Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease

@inproceedings{Hoekstra2011MitochondrialTI,
  title={Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease},
  author={Jake G. Hoekstra and Kathleen S. Montine and Jing Zhang and Thomas J. Montine},
  booktitle={Alzheimer's Research & Therapy},
  year={2011}
}
In neurons, mitochondria serve a wide variety of processes that are integral to their function and survival. It is, therefore, not surprising that evidence of mitochondrial dysfunction is observed across numerous neurodegenerative diseases. Alzheimer's disease and Parkinson's disease are two such diseases in which aberrant mitochondrial activity is proposed to contribute to pathogenesis. Current therapies for each disease target various mechanisms, but few, if any, directly target improved… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 61 references

Clinical practice. Early Alzheimer's disease.

The New England journal of medicine • 2010

Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.

Proceedings of the National Academy of Sciences of the United States of America • 2010

Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition • 2010